ILIlana Löwy

Ilana Löwy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ilana Löwy has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Covid long : une longue histoire

    by Ilana Löwy

    Les malades atteints de Covid long souffrent de symptômes multiples, mais les tests cliniques ne détectent aucune anomalie susceptible d’expliquer ces symptômes. En l’absence de signes objectifs d’une maladie reconnue, certains professionnels de santé considèrent qu’il s’agit d’une condition psychosomatique. Les malades sont ainsi confrontés à une « injustice épistémologique » : un manque de reconnaissance de leur souffrance. Une telle « injustice épistémologique » est enracinée dans une longue histoire des maladies « médicalement invisibles » qui ne peuvent être attestées qu’à travers le récit subjectif du malade. Les difficultés rencontrées par les malades de Covid long ne peuvent pas être dissociées de cette histoire.

  • Top Cited Papers
    Open Access

    The crisis in American science

    by Kathryn M. Olesko, Anthony Eames, Cyrus C. M. Mody, Ilana Löwy, Thomas Zeller, Mark Walker, Mitchell G. Ash, Donna Haraway

    The second regime of Donald J. Trump has decimated federal science and federally supported science to a greater degree than his first regime, unleashing an unprecedented crisis. The authors in this roundtable take a close look at the tortured landscape of science in America and, using historical scholarship and the tools of history, analyze and assess its plight. Topics include nuclear facilities, the role of Silicon Valley oligarchs, Executive Order 14168 on biological sex, climate change and the environmental sciences, science and ideology, responses to regime change, and resistance to the regime, especially by universities.


  • Open Access

    careers of chloroquine and hydroxychloroquine as “miraculous” anti-Covid-19 drugs

    by Luiz Villarinho Pereira Mendes, Claudia Garcia Serpa Osorio-De-Castro, Marilena Correa, Ilana Löwy

    In early January 2024, a widely publicized article in the journal Biomedicine and Pharmacology estimated that approximately 17,000 COVID-19 patients in France, Italy, Spain, Turkey, and the US died as a result of hydroxychloroquine treatment. The publication of this article is a fitting closure to nearly three years of controversy about the possible use of chloroquine and hydroxychloroquine to treat COVID-19. Repurposed in early 2020 as miracle answers to the COVID-19 pandemic, they had a brief moment of worldwide celebrity, despite the doubts expressed by many experts. Hydroxychloroquine’s career ended in September 2020, when a series of clinical trials showed not only inefficacy to treat COVID-19 but also safety concerns. However, the use of chloroquine and hydroxychloroquine continued in Brazil, where the government continued to promote their use as the first therapeutic choice against COVID-19. Our study outlines the employ of these drugs in France and Brazil. Grounded in the methodology developed by social studies of science, our article reconstructs the trajectories of hydroxychloroquine in France and Brazil. It aims to elucidate the reasons for the Brazilian exception, illuminating the disastrous consequences of the exercise of a monolithic political power and of anti-democratic practices on drug regulation and proposes new reflections on a topic that has been visible in the media and widely discussed in society, but attracted much less attention in the academic sphere.


  • Open Access

    Covid longa, a pandemia que não terminou

    by Jean Segata, Ilana Löwy

    Resumo O artigo explora a complexidade e as incertezas atuais sobre a covid longa, uma entidade nosológica emergente pós-covid-19, com contornos imprecisos e caracterizada por sintomas imprevisíveis e persistentes. Baseado em relatos de pessoas afetadas e equilibrando a revisão da literatura médica e jornalística sobre o tema, a história da ciência e a etnografia em saúde, o trabalho descreve e analisa as políticas de reconhecimento e de cuidado da doença em um contexto de injustiça epistêmica. O artigo contesta as representações da covid longa como uma condição meramente transitória, argumentando que, diferentemente das promessas de plena recuperação, o que tem ganhado forma é emergência de uma nova pessoa cuja biografia passa a ser reescrita com a covid longa. Para essas pessoas, o reconhecimento pleno da covid longa como uma entidade patológica distinta, aliado à validação de seu conhecimento experimental, significa mais do que simplesmente abrir possibilidades concretas para alívio do sofrimento físico e mental. Isso também representa justiça, reparação e um passo adiante na reconstrução de suas vidas.


  • Open Access

    Long COVID, the unending pandemic

    by Jean Segata, Ilana Löwy

    The article explores the complexity and current uncertainties concerning long COVID, an emerging nosological entity with vague contours and characterised by unpredictable and persistent symptoms and absence of ‘objective diagnosis’. Based on accounts of the affected individuals and balancing the review of medical and journalistic literature on the subject, historical approach and ethnography, this work describes and analyses the policies of recognition and care of this condition in a context of epistemic injustice. The article contests the representations of long COVID as a merely transient disorder arguing that, unlike the promises of full recovery, what is taking shape is the emergence of a new individual whose biography is being rewritten by long COVID. For these people, full recognition of long COVID as a distinct pathological entity, coupled with the validation of their experimental knowledge, means more than merely opening concrete possibilities for relief from physical and mental suffering. It also represents justice, repair, and a further step towards the reconstruction of their lives.


  • Open Access

    Absent data, diagnostic practices and the Zika conundrum

    by Ilana Löwy

    Dans sa présentation de l'atelier “Le déluge des données” Theodore Porter a expliqué que l'obstacle principal a la fusion des donnes médicaux des sources diverses est leur l'hétérogénéité : « toutefois il est possible de uniformiser des donnes a travers une régulation plus stricte. » L'étude de l'épidémie de Zika au Brésil (2015-2017) indique qu'une telle uniformisation peut être avant tout un problème politique. Zika est une maladie relativement bénigne, mais elle peut induire des malformations cérébrales sévères du fétus. La collection des données sur la prévalence de l'infection par le virus de Zika dans la population générale, et les risques d'une telle infection pour les femmes enceintes a été handicapée par l'absence des tests capables de détecter une infection et la difficulté de homogénéiser le diagnostic de syndrome congénital de Zika chez le nouveau-né. En principe ces problèmes ont pu être surmontes grâce au perfectionnement des tests diagnostiques et une régulation plus stricte. Toutefois, la diminution de la prévalence du Zika, couple avec l'observation que le syndrome congénital de Zika touche avant tous les populations défavorises dans les pays en voie de développement, a réduit considérablement les incitations d'investir dans l'homogénéisation des données sur cette condition. Dix années après le debout de l'épidémie de Zika au Brésil des informations essentielles sur cette épidémie manquent toujours.


  • Open Access

    Precision Medicine: Historiography of Life Sciences and the Geneticization of the Clinics**

    by Ilana Löwy

    In 2013, Hans Jörg Rheinberger proposed that Mendelian genetics and molecular biology were “scientific ideologies,” that is, for him they are systems of thought whose objects are hyperbolic; they are not, or not yet, in the realm of and not, or not yet, under the control of that system. This article proposes that precision medicine today is a scientific ideology and analyses the implications of this statement for historians of biology, genetics, and medicine.


  • Open Access

    « Si Fleck y est arrivé, je peux espérer y arriver aussi ! »

    by Ilana Löwy, Clémentine Gozlan, Jérôme Lamy, Marie Le Clainche-Piel, Arnaud Saint-Martin